“We need global awareness of lipoprotein (a),” Tremulis tells Fortune. “High lipoprotein (a) impacts one in five globally…And ...
The Powder Keg podcast investigates complaints of liver harm from users of a market-leading nutraceutical created by a New ...
Researchers at Karolinska Institutet and the University of Gothenburg have identified two types of metabolic-associated fatty ...
FDA approval streamlines Acetadote dosing, enhancing safety and efficiency in treating acetaminophen-related liver injury in ...
Sea, Essex, was told his blood and urine tests were clear before his symptom worsened. Now he's been told this Christmas will ...
AG1 founder Chris Ashenden. A podcast investigates complaints of liver harm from users of a market-leading nutraceutical ...
The term "nonalcoholic fatty liver disease" (NAFLD) has long been used to describe liver steatosis not related to excessive alcohol consumption ...
Under the agreements, AmMax and MD Anderson will build upon preclinical discoveries made by MD Anderson researchers to evaluate the potential for AMB-066, which targets colony stimulating factor 1 ...
Kidney stones, those painful crystalline formations in your urinary system, might soon be defeated by an innovative medical ...
Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a Tennessee-based specialty pharmaceutical company, saw its stock price surge by a remarkable 95.96% to $2.43 in Tuesday’s premarket trading session.
Galderma should launch its skin drug Nemluvio, to treat prurigo nodularis in the U.S. and Europe; Ipsen will bring its rare liver disease drug Iqirvo to market; and Sandoz is set to introduce a ...